$LAZ

Goldman Sachs raises Lazard stock price target on expense management

Goldman Sachs raised its price target for Lazard (NYSE:LAZ) to $35 from $32, maintaining a Sell rating. Lazard's Q3 2026 adjusted EPS of $0.36 missed estimates, with revenue 6% below expectations. Despite this, the company expects strong Financial Advisory performance and positive net organic flows in asset management. Goldman reduced its earnings estimates for 2026-2028 but increased its target P/E multiple.

Original reporting
Published Oct 22, 2026, 8:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$LAZ
Bearish
high confidence
Mentioned
$LAZ
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$LAZBearishLow
01

Why it matters

Earnings miss and lowered guidance drive negative sentiment; the modest target raise is unlikely to offset the sell pressure.

02

Market read

The earnings shortfall and revised forecasts are the primary drivers of market reaction for Lazard.

03

What to watch

Potential upside from upcoming M&A activity and pipeline strength not fully reflected in the price target.

Relevance 7/10Novelty 6/10Timing: after-hours reaction

Background

Lazard reported Q3 2026 adjusted EPS of $0.36 versus expectations of $0.44, with revenue $814M versus $848.6M expected. Goldman cut its earnings forecasts for 2026‑2028 and raised the target price to $35 while maintaining a Sell rating.

Company-level read

Ticker impact

$LAZBearishHigh confidence
Context

Goldman Sachs raised Lazard's price target to $35 after the company's Q3 earnings miss and lowered earnings estimates.

Expected impact

downward pressure as the market prices in the earnings shortfall and sell rating.

Evidence & confidence

The earnings miss and reduced forecasts outweigh the modest target increase, likely prompting short-term sell-offs.

Market effects

Highlights pressure on financial advisory and asset‑management firms facing earnings volatility.

Limited to U.S. and European investors tracking Lazard.

Modest, confined to the investment banking sector.

Counterpoint

The higher target may signal undervaluation, offering a potential buying opportunity on dip.

Key entities

  • Lazard Ltd.

    Global financial advisory and asset management firm.

  • Goldman Sachs

    Investment bank that issued the new price target and revised forecasts.

Related articles

$LAZMed

Citizens reiterates Lazard stock rating citing strong forward indicators

Citizens maintained its Market Outperform rating and $60.00 price target on Lazard (NYSE:LAZ) after its Q3 2026 results. Lazard reported adjusted EPS of $0.36, below estimates, and revenue of $805M, up 11% YoY but below expectations. Shares have fallen 21% YTD. Goldman Sachs raised its price target to $35 but kept a Sell rating, citing expense management. Lazard's dividend yield is 5.36%.

$LAZMed

Lazard Inc (LAZ) (Q3 2026) Earnings Call Highlights: Record Advisory Revenue

Lazard Inc (LAZ) reported Q3 2026 earnings with record advisory revenue but faced asset management outflows of $2.3B. CEO Peter Orszag highlighted growth opportunities from the Campbell Lutzens acquisition and strong advisory pipeline. CFO Tracy Farr discussed compensation ratio management. Management acknowledged macroeconomic challenges and potential M&A delays due to higher interest rates.

$LAZMed

What Lazard (LAZ) Said on Its Q3 Earnings Call

Lazard (LAZ) reported strong Q3 results, with advisory revenue split 61% M&A and 39% non-M&A. Conflict clearances rose 30%+ YoY, and its 2027 pipeline is twice 2026's. Asset management fees hit a record $321M, up 18% YoY, with AUM at $284B. Management expects H2 2026 to outperform H1, driven by strategic transactions and restructuring activity. The company returned $88M to shareholders and plans efficiency initiatives.

$LAZHighAI 8/10

Lazard (LAZ) Q3 2026 Earnings Call Transcript

Lazard (LAZ) reported Q3 2026 earnings, highlighting 11% year-over-year revenue growth. The firm plans to close its acquisition of Campbell Lutyens, launching Lazard CL, expected to generate $500M in 2027 revenue. Financial advisory saw record revenue, with strong forward indicators and pipeline growth. Asset management reported record gross inflows of $54B for the first nine months.

$LAZMed

Why Lazard (LAZ) stock is trading lower today

Lazard (LAZ) shares fell 3% after Q3 earnings missed estimates, with adjusted EPS of $0.36 vs. $0.44 expected and revenue of $814M vs. $848.6M projected. The company reported net income of $29M, or $0.26 per share. The stock was trading at $36.18, down 36.5% from its 52-week high.

$LAZMed

Lazard misses Q3 estimates on revenue and earnings

Lazard Ltd. (NYSE:LAZ) reported Q3 earnings of $0.36 per share, missing estimates by $0.08, with revenue at $814M, below the $848.6M forecast. Adjusted net revenue rose 11% YoY to $805M. Financial Advisory and Asset Management segments saw 10% and 12% YoY growth, respectively. CEO Peter Orszag highlighted strong momentum and record quarterly revenue in Financial Advisory. AUM increased 7% YoY to $284B. The company returned $88M to shareholders via dividends and buybacks.